Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Trafficking and folding of the hERG ion channel: implications for long QT syndrome type 2
EF 2020-21
Résumé
Cardiovascular disease is the number one cause of death worldwide. Dysfunction of the hERG/Kv11.1 ion channel is responsible for long QT syndrome type 2 (LQT2), which increases the risk of arrhythmia and cardiac arrest and is present in 1/2500 Caucasians. LQT2 patients have a single mutant copy of the gene, with mutations being linked to misfolding of the protein. A hERG channel consists of 4 copies of protein, and each can be either of two isoforms: hERG-1a is full length protein, while hERG-1b is missing the amino terminal domain. Since 1a can form functional channels alone while 1b cannot, most past research has focused only on 1a. However, channels with both 1a and 1b have different physiological properties. Hence, the molecular mechanisms behind LQT2 remain poorly characterized. We propose 2 mechanisms for LQT2: 1) Dominant negative (DN):mutant subunits associate with wild-type (WT) ones, making a non-functional channel. 2) Haploinsufficient (HI): mutant subunits do not associate with WT, meaning all surface channels are functional, but there are approximately half as many. Our preliminary research indicates that disease mutants lie on a spectrum between DN and HI. Using a model co-expression (1a/1b) system, we aim to determine the DN or HI mechanisms of LQT2-causing mutations, and correlate them to the molecular structure of hERG. We constructed mutant and normal genes with different tags so we can observe their interaction and localization. The results will be validated in human cardiomyocytes gene-edited with the mutations. With a better understanding of the folding and trafficking of hERG channels, our research will help predict the severity of disease for patients with known and novel LQT2 mutations and allow for the development of targeted treatments.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
449632
Name
Read John
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Trafficking and folding of the hERG ion channel: implications for long QT syndrome type 2
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Arrhythmia; Cardiac; Electrophysiology; Folding; Ion Channel; Physiology; Potassium; Protein; Tetramerization; Trafficking
Abstract
Cardiovascular disease is the number one cause of death worldwide. Dysfunction of the hERG/Kv11.1 ion channel is responsible for long QT syndrome type 2 (LQT2), which increases the risk of arrhythmia and cardiac arrest and is present in 1/2500 Caucasians. LQT2 patients have a single mutant copy of the gene, with mutations being linked to misfolding of the protein. A hERG channel consists of 4 copies of protein, and each can be either of two isoforms: hERG-1a is full length protein, while hERG-1b is missing the amino terminal domain. Since 1a can form functional channels alone while 1b cannot, most past research has focused only on 1a. However, channels with both 1a and 1b have different physiological properties. Hence, the molecular mechanisms behind LQT2 remain poorly characterized. We propose 2 mechanisms for LQT2: 1) Dominant negative (DN):mutant subunits associate with wild-type (WT) ones, making a non-functional channel. 2) Haploinsufficient (HI): mutant subunits do not associate with WT, meaning all surface channels are functional, but there are approximately half as many. Our preliminary research indicates that disease mutants lie on a spectrum between DN and HI. Using a model co-expression (1a/1b) system, we aim to determine the DN or HI mechanisms of LQT2-causing mutations, and correlate them to the molecular structure of hERG. We constructed mutant and normal genes with different tags so we can observe their interaction and localization. The results will be validated in human cardiomyocytes gene-edited with the mutations. With a better understanding of the folding and trafficking of hERG channels, our research will help predict the severity of disease for patients with known and novel LQT2 mutations and allow for the development of targeted treatments.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Read, John
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~